IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barletta, J. P.
Right arrow Articles by Schultz, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barletta, J. P.
Right arrow Articles by Schultz, G. S.

Investigative Ophthalmology & Visual Science, Vol 37, 20-28, Copyright © 1996 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor

JP Barletta, G Angella, KC Balch, HG Dimova, GA Stern, MT Moser, GB van Setten and GS Schultz
Department of Ophthalmology, University of Florida School of Medicine, Gainesville, USA.

PURPOSE. To evaluate the effect of the synthetic matrix metalloproteinase inhibitor, Galardin, on proteases produced by Pseudomonas aeruginosa (PA) and on a rabbit model of Pseudomonas keratitis. METHODS. Protease activities of culture broths from Pseudomonas strains PA-28 and W-186 were characterized in vitro by gelatin zymography and by digestion of Azocasein in the presence and absence of Galardin and the serine protease inhibitor, aprotinin. In a noninfectious in vivo experiment, sterile PA culture broth from W-186 was injected intrastromally into rabbit corneas that were treated topically with Galardin or vehicle, then evaluated clinically and histologically. In an infectious in vivo experiment, rabbit corneas were injected with washed PA-28, then treated topically with Galardin or vehicle and clinically scored. RESULTS. Gelatin zymography of culture broth from W-186 and PA-28 detected two proteases that were both inhibited by Galardin. Galardin reduced the digestion of Azocasein by both PA culture broths by 99%, whereas aprotinin did not significantly reduce the protease activity of PA-28 conditioned broth. Intrastromal injection of sterile W-186 culture broth caused rapid corneal destruction that was prevented by topical treatment with Galardin. Intrastromal injection of washed PA-28 bacteria resulted in progressive corneal melting that was significantly (P < 0.005) delayed, but ultimately not prevented, by topical treatment with Galardin. CONCLUSIONS. Pseudomonal protease activity in culture broth consisted predominantly of metalloproteinases and were effectively inhibited by Galardin in vitro. Topical treatment with Galardin prevented destruction of rabbit corneas by bacterial products present in culture broth, and it delayed corneal destruction after injection of PA bacteria. Galardin may be a useful adjuvant when corneal destruction proceeds despite prompt antibiotic treatment.


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
S. S. Kocer, S. G. Walker, B. Zerler, L. M. Golub, and S. R. Simon
Metalloproteinase Inhibitors, Nonantimicrobial Chemically Modified Tetracyclines, and Ilomastat Block Bacillus anthracis Lethal Factor Activity in Viable Cells
Infect. Immun., November 1, 2005; 73(11): 7548 - 7557.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. L. Xue, D. Wakefield, M. D. P. Willcox, A. R. Lloyd, N. Di Girolamo, N. Cole, and A. Thakur
Regulation of MMPs and TIMPs by IL-1{beta} during Corneal Ulceration and Infection
Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2020 - 2025.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. T. L. Wong, A. L. Mead, and P. T. Khaw
Matrix Metalloproteinase Inhibition Modulates Postoperative Scarring after Experimental Glaucoma Filtration Surgery
Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1097 - 1103.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. M. Sheridan, N. L. Occleston, P. Hiscott, C. H. Kon, P. T. Khaw, and I. Grierson
Matrix Metalloproteinases : A Role in the Contraction of Vitreo-Retinal Scar Tissue
Am. J. Pathol., October 1, 2001; 159(4): 1555 - 1566.
[Abstract] [Full Text]

Home page
 IOVSHome page
K. A. Kernacki, R. Barrett, and L. D. Hazlett
Evidence for TIMP-1 Protection Against P. aeruginosa-Induced Corneal Ulceration and Perforation
Invest. Ophthalmol. Vis. Sci., December 1, 1999; 40(13): 3168 - 3176.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
C. Sotozono, J. He, M. Tei, Y. Honma, and S. Kinoshita
Effect of Metalloproteinase Inhibitor on Corneal Cytokine Expression after Alkali Injury
Invest. Ophthalmol. Vis. Sci., September 1, 1999; 40(10): 2430 - 2434.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
F. G. Spinale, M. L. Coker, S. R. Krombach, R. Mukherjee, H. Hallak, W. V. Houck, M. J. Clair, S. B. Kribbs, L. L. Johnson, J. T. Peterson, et al.
Matrix Metalloproteinase Inhibition During the Development of Congestive Heart Failure : Effects on Left Ventricular Dimensions and Function
Circ. Res., August 20, 1999; 85(4): 364 - 376.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. L. Coker, C. V. Thomas, M. J. Clair, J. W. Hendrick, R. S. Krombach, Z. S. Galis, and F. G. Spinale
Myocardial matrix metalloproteinase activity and abundance with congestive heart failure
Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1516 - H1523.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Association for Research in Vision and Ophthalmology